Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 3 Sarcoma 1 Neoplasm Metastasis 1 Carcinoma 1 Bronchial Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Doxorubicin 14 pembrolizumab 11 Specimen Handling 11 Magnetic Resonance Spectroscopy 10 Biopsy 9 Cyclophosphamide 8 X-Rays 7 Radiotherapy 7 Nivolumab 7 Ifosfamide 7 Phantoms, Imaging 6 Gemcitabine 6 liposomal doxorubicin 5 Temozolomide 5 Radiation 5 tazemetostat 4 palbociclib 4 Trabectedin 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 Ipilimumab 4 pazopanib 3 larotrectinib 3 fludarabine 3 cabozantinib 3 atezolizumab 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Proton Therapy 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × capmatinib × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡